Wall Street analysts predict that Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Rating) will post earnings per share (EPS) of $0.57 for the current quarter, according to Zacks. Five analysts have issued estimates for Teva Pharmaceutical Industries’ earnings. The lowest EPS estimate is $0.53 and the highest is $0.60. Teva Pharmaceutical Industries reported earnings of […]
Wall Street brokerages expect Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Rating) to report earnings per share of $0.55 for the current fiscal quarter, Zacks reports. Five analysts have made estimates for Teva Pharmaceutical Industries’ earnings. The highest EPS estimate is $0.61 and the lowest is $0.50. Teva Pharmaceutical Industries posted earnings of $0.63 per […]
Teva Pharmaceutical Industries (NYSE:TEVA – Get Rating) will be issuing its quarterly earnings data before the market opens on Tuesday, May 3rd. Analysts expect the company to announce earnings of $0.53 per share for the quarter. Teva Pharmaceutical Industries has set its FY 2022 guidance at $2.400-$2.600 EPS.Persons that are interested in participating in the […]
Equities research analysts forecast that Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Rating) will report earnings of $0.55 per share for the current fiscal quarter, according to Zacks. Five analysts have provided estimates for Teva Pharmaceutical Industries’ earnings. The highest EPS estimate is $0.61 and the lowest is $0.50. Teva Pharmaceutical Industries posted earnings of […]
Teva Pharmaceutical Industries (NYSE:TEVA – Get Rating) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Tuesday. Other research analysts have also recently issued reports about the stock. Sanford C. Bernstein raised shares of Teva Pharmaceutical Industries from a “market perform” rating […]